Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer
Lingfan Xu, Yu Yin, Yanjing Li, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 13
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Amino acid metabolism in health and disease
Zhenan Ling, Yifan Jiang, Jun-Nan Ru, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 192
The Global Research of Artificial Intelligence on Prostate Cancer: A 22-Year Bibliometric Analysis
Zefeng Shen, Haiyang Wu, Zeshi Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 75
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 51
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
Dongming Li, Donghui Cao, Yuanlin Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15
Understanding and targeting prostate cancer cell heterogeneity and plasticity
Dean G. Tang
Seminars in Cancer Biology (2021) Vol. 82, pp. 68-93
Open Access | Times Cited: 60
Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction
Zheng Liu, Lei Wang, Qichang Xing, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 43
Metabolic Reprogramming of Tumor-Associated Macrophages Using Glutamine Antagonist JHU083 Drives Tumor Immunity in Myeloid-Rich Prostate and Bladder Cancers
Monali Praharaj, Fan Shen, Alex J. Lee, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 7, pp. 854-875
Open Access | Times Cited: 13
The Cancer Antioxidant Regulation System in Therapeutic Resistance
Xuanhao Gu, Chunyang Mu, Rujia Zheng, et al.
Antioxidants (2024) Vol. 13, Iss. 7, pp. 778-778
Open Access | Times Cited: 9
Cyclin‐dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration‐resistant prostate cancer
Haozhe Zhang, Yi Zhou, Yating Feng, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 5
Open Access | Times Cited: 6
Glutamine Metabolism and Prostate Cancer
Holger H.H. Erb, Nikita Polishchuk, Oleh Stasyk, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2871-2871
Open Access | Times Cited: 6
Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
Huan Xu, Yanbo Chen, Meng Gu, et al.
Metabolites (2021) Vol. 11, Iss. 11, pp. 765-765
Open Access | Times Cited: 33
Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatment
Jasmin Sponagel, Jill K. Jones, Cheryl Frankfater, et al.
Med (2022) Vol. 3, Iss. 11, pp. 792-811.e12
Open Access | Times Cited: 26
Targeting Glutamine Metabolism in Prostate Cancer
Neil A. Bhowmick, Edwin M. Posadas, Leigh Ellis, et al.
Frontiers in Bioscience-Elite (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 14
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancer
Alicia-Marie K. Beier, Celina Ebersbach, Tiziana Siciliano, et al.
Oncogene (2024) Vol. 43, Iss. 26, pp. 2038-2050
Open Access | Times Cited: 5
Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy
Dongming Li, Donghui Cao, Yangyu Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Cellular Signaling of Amino Acid Metabolism in Prostate Cancer
Ping Yao, Shiqi Cao, Zhiguang Zhu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 776-776
Open Access
Mitochondrial GCN5L1 regulates glutaminase acetylation and hepatocellular carcinoma
Taotao Zhang, Yunlong Cui, Yanjin Wu, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 21
Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer
Lingfan Xu, Bing Zhao, William Butler, et al.
Oncogene (2022) Vol. 41, Iss. 8, pp. 1140-1154
Open Access | Times Cited: 20
The role of glutamine metabolism in castration-resistant prostate cancer
Bing Zhao, Jing Wang, Li Chen, et al.
Asian Journal of Andrology (2023)
Open Access | Times Cited: 9
MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer
Preston D. Crowell, Jenna M. Giafaglione, Anthony E. Jones, et al.
Cell Reports (2023) Vol. 42, Iss. 10, pp. 113221-113221
Open Access | Times Cited: 9
Heat shock factor 1 directly regulates transsulfuration pathway to promote prostate cancer proliferation and survival
J. Spencer Hauck, David Moon, Xue Jiang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 3
Personalized Medicine for Prostate Cancer: Is Targeting Metabolism a Reality?
Gio Fidelito, Matthew J. Watt, Renea A. Taylor
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 15
More Than Meets the Eye: Scientific Rationale behind Molecular Imaging and Therapeutic Targeting of Prostate-Specific Membrane Antigen (PSMA) in Metastatic Prostate Cancer and Beyond
Anniina Hyväkkä, Verneri Virtanen, Jukka Kemppainen, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2244-2244
Open Access | Times Cited: 20
High-resolution structures of mitochondrial glutaminase C tetramers indicate conformational changes upon phosphate binding
Thuy‐Tien T. Nguyen, Sekar Ramachandran, Matthew J. Hill, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 2, pp. 101564-101564
Open Access | Times Cited: 13
Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
Eliot B. Blatt, Karla Parra, Antje Neeb, et al.
Oncogene (2023) Vol. 42, Iss. 30, pp. 2347-2359
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top